Word

LUMVYTA

Status

Dead

Status Code

602

Status Date

Saturday, June 24, 2023

Serial Number

97417578

Mark Type

4000

Filing Date

Wednesday, May 18, 2022

Abandoned Date

Friday, June 9, 2023

Trademark Owner History

Day One Biopharmaceuticals, Inc.

Classifications

5 Pharmaceutical preparations; pharmaceutical preparations for human use; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; targeted medical preparations for use in the field of cancer prevention and treatment; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

44 Medical information services; healthcare services; research, development, and evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; design, development, research, and testing of drugs and pharmaceuticals for the treatment and/or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical information services, namely, providing information regarding viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events

Jun 26, 2023

Abandonment Notice E-Mailed - Failure To Respond

Jun 24, 2023

Abandonment Notice Mailed - Failure To Respond

Jun 24, 2023

Abandonment - Failure To Respond Or Late Response

Mar 8, 2023

Notification Of Non-Final Action E-Mailed

Mar 8, 2023

Non-Final Action E-Mailed

Mar 8, 2023

Non-Final Action Written

Mar 7, 2023

Assigned To Examiner

Sep 14, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Sep 14, 2022

Teas Change Of Correspondence Received

Sep 14, 2022

Teas Change Of Owner Address Received

May 24, 2022

New Application Office Supplied Data Entered

May 21, 2022

New Application Entered